Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Bio2RDF uri

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

http://bio2rdf.org/clinicaltrials:NCT00569777

Bio2RDF identifier

NCT00569777

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00569777

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00569777

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

310

http://www.w3.org/2001/XMLSchema#integer

brief summary [clinicaltrials_vocabulary:brief-summary]

The purpose of this stu ...... althy normal volunteers

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

http://www.w3.org/2001/XMLSchema#string

clinical result [clinicaltrials_vocabulary:clinical-result]

clinical results for clinicaltrials:NCT00569777 [clinicaltrials_resource:9ac9449b8581d78b4b0c2a0bd669d26b]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:11bfce48597a5ebe2d027bf507d5ee3a]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:289548fc50252fa79cfa68b0c51f45c5]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:2fe42b4f0183db24e44e811cd947625a]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:34d73d3607718357b81effbf70fba75b]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:386271b78c2929b89c1a235cdaaf47c2]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:39151cdd843d25069abfbe45ea8c8168]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:56fdc83902be9d25d099510210501333]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:5c5df0f1fbefb22e5b757da2da349c2b]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:7073531c013378fe308832c0b454bec4]

Lid and Lid Margin Erythema, Change From Baseline baseline and 12 weeks [clinicaltrials_resource:71842a3207745de1f30d1b68a6a002bf]

completion date [clinicaltrials_vocabulary:completion-date]

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Allergic Conjunctivitis [clinicaltrials_resource:20ace2b3eae931e5d03473022d5ca611]

condition browse [clinicaltrials_vocabulary:condition-browse]

Conjunctivitis, Allergic [clinicaltrials_resource:10e7ff2e7aeb5b689d7e989cc6e0142b]

Conjunctivitis [clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Conjunctivitis, Allergic [clinicaltrials_resource:10e7ff2e7aeb5b689d7e989cc6e0142b]

Conjunctivitis [clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a]

country [clinicaltrials_vocabulary:country]

United States [clinicaltrials_resource:f253efe302d32ab264a76e0ce65be769]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00569777 [clinicaltrials_resource:c25fffd4c27a59f3736407088b5fb73b]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2007-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]

2010-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

K-Lens (generic name not established) and Ketotifen [clinicaltrials_resource:f46dbe38308fa6f0ac36de7179aaeb62]

Placebo Lens [clinicaltrials_resource:f680dcb4095d00564b32aeb1868e55d3]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Ketotifen [clinicaltrials_resource:a3823a428196dc3da9d025b249d246a0]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

Yes

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Vistakon Pharmaceuticals [clinicaltrials_resource:9c2effea37298b988ed64d69af3348a5]

location [clinicaltrials_vocabulary:location]

[clinicaltrials_resource:469704a4da816d729ec37eb607010452]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00569777

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Multi-Center, Randomized, Do ...... in Healthy, Normal Volunteers

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

07-003-002

http://www.w3.org/2001/XMLSchema#string

outcome [clinicaltrials_vocabulary:outcome]

Lid and Lid Margin Erythema, Change From Baseline [clinicaltrials_resource:NCT00569777/outcome/1]

overall official [clinicaltrials_vocabulary:overall-official]

Brian Pall, OD, MS, FAAO [clinicaltrials_resource:99ecaeb57699f92fc12e6f3ddd0c9c46]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:9100d3aba3db750eb2a6b33c1123ddfa]

participant flow [clinicaltrials_vocabulary:participant-flow]

participant flow for clinicaltrials:NCT00569777 [clinicaltrials_resource:e686b10a20ed625d2fb523d2d344c7b7]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reported events [clinicaltrials_vocabulary:reported-events]

Reported events for NCT00569777 [clinicaltrials_resource:fd2fe9920b83c33123ea2e1c44b20d0f]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

Vistakon Pharmaceuticals [clinicaltrials_resource:9c2effea37298b988ed64d69af3348a5]

start date [clinicaltrials_vocabulary:start-date]

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00569777 study design [clinicaltrials_resource:1e063903ff7fba1063cc18de74644077]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00569777

verification date [clinicaltrials_vocabulary:verification-date]

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00569777

http://www.w3.org/2001/XMLSchema#string

title

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

@en